Brian M. Culley

2022 - BioTime

In 2022, Brian M. Culley earned a total compensation of $2.4M as Chief Executive Officer at BioTime, a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$319,900
Option Awards$1,159,875
Salary$609,000
Stock Awards$268,503
Other$15,250
Total$2,372,528

Culley received $1.2M in option awards, accounting for 49% of the total pay in 2022.

Culley also received $319.9K in non-equity incentive plan, $609K in salary, $268.5K in stock awards and $15.3K in other compensation.

Rankings

In 2022, Brian M. Culley's compensation ranked 1,483rd out of 5,387 executives tracked by ExecPay. In other words, Culley earned more than 72.5% of executives.

ClassificationRankingPercentile
All
1,483
out of 5,387
73rd
Division
Manufacturing
752
out of 2,922
74th
Major group
Chemicals And Allied Products
289
out of 1,304
78th
Industry group
Drugs
267
out of 1,209
78th
Industry
Biological Products, Except Diagnostic Substances
69
out of 280
75th
Source: SEC filing on July 27, 2023.

Culley's colleagues

We found three more compensation records of executives who worked with Brian M. Culley at BioTime in 2022.

2022

Kevin Cook

BioTime

Chief Financial Officer

2022

George Samuel

BioTime

General Counsel

2022

Jill Howe

BioTime

Chief Financial Officer

News

You may also like